Skip to main content
. Author manuscript; available in PMC: 2014 Jul 2.
Published in final edited form as: Sci China Life Sci. 2013 Jul 13;56(9):780–787. doi: 10.1007/s11427-013-4522-0

Table 1.

The prevalence of key genetic events for prostate carcinogenesis among different ethnic groups

Genetic alteration Prevalance in
Asian patients (%)
Frequency in patients
from Western
countries (%)
ERG-TMPRSS2 fusion 8–21 [19,2123] 50–70 [17]
PTEN inactivation 34 [24] 70 [24,30]
CTAGE-KHDRBS3 fusion 37 [21] Unkown
USP9Y-TTTY15 fusion 35 [21] Unkown
KRAS mutations 7–17 [2529] Up to 3 [25,31]
BRAF copy number gain 29 [28] 9 [28]